The article examines how targeted deletion of the sclerostin gene in laboratory mice resulted in increased bone formation and bone strength. Sclerosteosis is a high bone mass genetic abnormality in humans caused by inactivating mutations in SOST, which in the gene encoding sclerostin. Based on this information, sclerostin has become a major negative regulator of bone mass.